Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP351199.RAdeeXFCc-ZG6igz_j72i2Jc3PMZV-13rlsvRgWOAZv6M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP351199.RAdeeXFCc-ZG6igz_j72i2Jc3PMZV-13rlsvRgWOAZv6M130_assertion type Assertion NP351199.RAdeeXFCc-ZG6igz_j72i2Jc3PMZV-13rlsvRgWOAZv6M130_head.
- NP351199.RAdeeXFCc-ZG6igz_j72i2Jc3PMZV-13rlsvRgWOAZv6M130_assertion wasGeneratedBy ECO_0000203 NP351199.RAdeeXFCc-ZG6igz_j72i2Jc3PMZV-13rlsvRgWOAZv6M130_provenance.
- NP351199.RAdeeXFCc-ZG6igz_j72i2Jc3PMZV-13rlsvRgWOAZv6M130_assertion wasDerivedFrom befree-20140225 NP351199.RAdeeXFCc-ZG6igz_j72i2Jc3PMZV-13rlsvRgWOAZv6M130_provenance.
- NP351199.RAdeeXFCc-ZG6igz_j72i2Jc3PMZV-13rlsvRgWOAZv6M130_assertion SIO_000772 17635819 NP351199.RAdeeXFCc-ZG6igz_j72i2Jc3PMZV-13rlsvRgWOAZv6M130_provenance.
- NP351199.RAdeeXFCc-ZG6igz_j72i2Jc3PMZV-13rlsvRgWOAZv6M130_assertion evidence source_evidence_literature NP351199.RAdeeXFCc-ZG6igz_j72i2Jc3PMZV-13rlsvRgWOAZv6M130_provenance.
- NP351199.RAdeeXFCc-ZG6igz_j72i2Jc3PMZV-13rlsvRgWOAZv6M130_assertion description "[While the significance of increased FGF23 levels in CKD remains to be defined, it might contribute to phosphate excretion and suppression of 1,25(OH)(2)D levels in CKD stages 3 and 4, as well as potentially contribute to secondary hyperparathyroidism through direct actions on the parathyroid gland in more advanced renal failure.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP351199.RAdeeXFCc-ZG6igz_j72i2Jc3PMZV-13rlsvRgWOAZv6M130_provenance.